Stoke Therapeutics, Inc. STOK
Set alert
26.29 USD -0.06 -0.23%
At close · Oct 30
27.00 +0.71 +2.70%
After hours · Oct 30, 4:33 PM ET
25.86 Day range 26.72
22.37 52-week range 38.35
- YTD
- -17.17%
- 1 year
- -17.07%
- Open
- 26.04
- Prev close
- 26.35
- Mkt cap
- 1.70B
- Vol
- 1.86M
- Avg vol
- 1.03M
- EPS
- -3.81
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 25.86
- High
- 26.72
- Forward P/E
- -7.45
- Beta
- 1.26
- Short ratio
- 10.28
- Inst. own
- 125.47%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Mar 15, 2027
- 50-d avg
- 27.53
- 200-d avg
- 30.94
- 1y target
- 46.46
Financial health
Altman Z-Score
15.46 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
D+1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 2
Valuation
P/E -265×
FY 2017 5y median -6.7× FY 2025
P/S 10.2×
FY 2017 5y median 16.3× FY 2025
P/B 5.3×
FY 2017 5y median 2.6× FY 2025
P/FCF 41.8×
FY 2017 5y median -6.8× FY 2025
EV/EBITDA -352×
FY 2017 5y median -5.4× FY 2025
EV/Sales 9.8×
FY 2017 5y median 9.8× FY 2025
FCF Yield 2.4%
FY 2017 5y median -10.0% FY 2025
Profitability
Gross Margin 100.0%
FY 2017 5y median 100.0% FY 2025
Operating Margin -11.2%
FY 2017 5y median -277.3% FY 2025
Net Margin -3.7%
FY 2017 5y median -243.4% FY 2025
ROE -2.0%
FY 2017 5y median -39.4% FY 2025
ROIC -5.7%
FY 2017 5y median -43.4% FY 2025
ROA -1.6%
FY 2017 5y median -35.9% FY 2025
Growth (YoY)
Revenue 404.5%
FY 2017 FY 2025
Operating Income 79.7%
FY 2017 FY 2025
EPS (diluted) 92.7%
FY 2017 FY 2025
Free Cash Flow 151.6%
FY 2017 FY 2025
Financial Health
Current Ratio 5.3×
FY 2017 5y median 7.0× FY 2025
Quick Ratio 5.3×
FY 2017 5y median 7.0× FY 2025
Debt / Equity 0.0×
FY 2017 5y median 0.0× FY 2025
Net Debt / EBITDA 15.9×
FY 2017 5y median 1.6× FY 2025
Interest Coverage -2288×
FY 2017 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31